全球無細胞療法市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

無細胞療法市場預計將從 2025 年的 142.6 億美元成長到 2034 年的 562.2 億美元，2026 年至 2034 年的複合年成長率為 16.47%。

隨著再生醫學的進步，全球無細胞療法市場正受到廣泛關注。無細胞療法利用不含活細胞的生物材料和細胞外基質，正日益廣泛應用於組織修復和創傷治療等領域。對微創再生療法的需求不斷成長，以及生物材料科學的進步，正推動著各個治療領域的市場成長。

慢性傷口、整形外科疾病和心血管疾病的日益普遍是推動成長要素。與以細胞為基礎的治療方法相比，無細胞產品具有許多優勢，例如免疫反應較低、疾病傳播風險較小。此外，研究活動的活性化、臨床試驗的增加以及監管核准的加速也正在加速產品的開發和商業化進程。

展望未來，支架技術和生物來源材料的持續創新有望推動市場發展。皮膚科、整形外科和重組外科等領域的應用拓展將進一步促進其普及。再生醫學領域投資的增加以及政府的支持措施，有望為全球無細胞療法市場帶來強勁的長期成長前景。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球無細胞療法市場：依疾病分類

• 市場分析、洞察與預測
• 帕金森氏症
• 阿茲海默症
• 慢性傷口
• 硬化
• 癌症

第5章 全球無細胞療法市場：按應用分類

• 市場分析、洞察與預測
• 肝病學
• 整形外科
• 心臟病學
• 神經病學
• 腫瘤學
• 胃腸病學

第6章：全球無細胞療法市場：依支架類型分類

• 市場分析、洞察與預測
• 熔融沈積成型（FDM）
• 含細胞水凝膠
• 細胞外基質（ECM）
• 選擇性雷射燒結（SLS）

第7章 全球無細胞療法市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Codiak BioSciences Ltd
  • Evox Therapeutics Ltd
  • Stem Cell Medicine Ltd
  • Capricor Therapeutics
  • Exogenous Therapeutics
  • Organicell Regenerative Medicine Inc
  • Aegle Therapeutics Corp
  • ArunA Biomedical
  • Rion LLC
  • Invitrx Therapeutics Inc
  • Direct Biologics LLC
  • Stem Cell Medicine Ltd

The Acellular Therapy Market size is expected to reach USD 56.22 Billion in 2034 from USD 14.26 Billion (2025) growing at a CAGR of 16.47% during 2026-2034.

The Global Acellular Therapy Market is gaining traction as regenerative medicine continues to evolve. Acellular therapies, which use biomaterials and extracellular matrices without living cells, are increasingly being adopted for tissue repair and wound healing applications. Growing demand for minimally invasive regenerative treatments and advancements in biomaterial science are supporting market growth across various therapeutic areas.

Key growth drivers include increasing prevalence of chronic wounds, orthopedic disorders, and cardiovascular conditions. Acellular products offer advantages such as reduced immune response and lower risk of disease transmission compared to cell-based therapies. Rising research activities, clinical trials, and regulatory approvals are also accelerating product development and commercialization.

Looking forward, the market is expected to benefit from ongoing innovation in scaffold technologies and biologically derived materials. Expanding applications in dermatology, orthopedics, and reconstructive surgery will further drive adoption. Increasing investments in regenerative medicine and supportive government initiatives are likely to create strong long-term growth prospects for the global acellular therapy market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Disease

• Parkinson's
• Alzheimer's
• Chronic Wounds
• Sclerosis
• Cancer

By Application

• Hepatology
• Orthopedic
• Cardiology
• Neurology
• Oncology
• Gastroenterology

By Scaffold

• Fused Deposition Modeling (FDM)
• Cell Laden Hydrogel
• Extracellular Matrix (ECM)
• Selective Laser Sintering (SLS)

COMPANIES PROFILED

• Codiak BioSciences Ltd, Evox Therapeutics Ltd, Stem Cell Medicine Ltd, Capricor Therapeutics, Exogenous Therapeutics, Organicell Regenerative Medicine Inc, Aegle Therapeutics Corp, ArunA Biomedical, Rion LLC, Invitrx Therapeutics Inc, Direct Biologics LLC, Stem Cell Medicine Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ACELLULAR THERAPY MARKET: BY DISEASE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease
• 4.2. Parkinson's Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Alzheimer's Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Chronic Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sclerosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ACELLULAR THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Hepatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ACELLULAR THERAPY MARKET: BY SCAFFOLD 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Scaffold
• 6.2. Fused Deposition Modeling (FDM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cell Laden Hydrogel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Extracellular Matrix (ECM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Selective Laser Sintering (SLS) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ACELLULAR THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Disease
  • 7.2.2 By Application
  • 7.2.3 By Scaffold
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Disease
  • 7.3.2 By Application
  • 7.3.3 By Scaffold
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Disease
  • 7.4.2 By Application
  • 7.4.3 By Scaffold
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Disease
  • 7.5.2 By Application
  • 7.5.3 By Scaffold
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Disease
  • 7.6.2 By Application
  • 7.6.3 By Scaffold
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ACELLULAR THERAPY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Codiak BioSciences Ltd
  • 9.2.2 Evox Therapeutics Ltd
  • 9.2.3 Stem Cell Medicine Ltd
  • 9.2.4 Capricor Therapeutics
  • 9.2.5 Exogenous Therapeutics
  • 9.2.6 Organicell Regenerative Medicine Inc
  • 9.2.7 Aegle Therapeutics Corp
  • 9.2.8 ArunA Biomedical
  • 9.2.9 Rion LLC
  • 9.2.10 Invitrx Therapeutics Inc
  • 9.2.11 Direct Biologics LLC
  • 9.2.12 Stem Cell Medicine Ltd